Corporate Profile
Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. We share a vision of repairing and controlling genes, replacing missing or damaged cells, and making our therapies broadly available to patients. We are working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
News Releases
Mar 16, 2023
Mar 14, 2023
Mar 01, 2023
Events
Mar 8, 2023 at 9:50 AM EST
Feb 9, 2023 at 1:00 PM EST
SEC Filings
| Filing date | Description | Form |
|---|---|---|
| D | ||
| D | ||
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy |
DRS |